J. Booij et al., Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats, EUR J NUCL, 25(12), 1998, pp. 1666-1669
Citations number
15
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Medical Research Diagnosis & Treatment
Iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)nortropane (no
r-beta-CIT), a radioiodinated cocaine analogue, was evaluated as an agent f
or the in vivo labelling of serotonin transporters by biodistribution studi
es in rats. Intravenous injection of [I-123]nor-beta-CIT resulted in high a
ccumulation of radioactivity in brain areas with high densities of serotoni
n (hypothalamus) and dopamine transporters (striatum), although the binding
was less pronounced in the hypothalamus. While binding of [I-123]nor-beta-
CIT in the hypothalamus was blocked significantly by fluvoxamine (a selecti
ve serotonin transporter blocker) but not by GBR12,909 (a selective dopamin
e transporter blocker), the opposite was observed in the striatum. The resu
lts of this study indicate that [I-123]nor-beta-CIT, although not being a s
elective radioligand, binds specifically to serotonin transporters in the h
ypothalamus in vivo and thus suggest that [I-123]nor-beta-CIT promises to b
e a suitable radioligand for single-photon emission tomography imaging of s
erotonin transporters in humans.